Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

Shanyu Pill

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-09-04 — Effects of Shanyu Pill in Older Adults With Sarcopenia: Protocol registered for a 24-week multicenter double-blind placebo-controlled RCT (n=192) of Shanyu Pill in older adults with sarcopenia; primary outcome is change in appendicular skeletal muscle mass index, with secondary strength, physical performance, cognition, and TCM Spleen Qi Deficiency score endpoints plus gut–muscle–brain mechanistic substudies — trial launch only, no efficacy readout. [human-rct] (novelty: 3)

Open questions

Related

Contributing findings

clinicaltrials trial early human-rct
Effects of Shanyu Pill in Older Adults With Sarcopenia
04-sep-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18